IBRELAT Trademark

Trademark Overview

On Friday, October 13, 2006, a trademark application was filed for IBRELAT with the United States Patent and Trademark Office. The USPTO has given the IBRELAT trademark a serial number of 77020749. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 1, 2016. This trademark is owned by AstraZeneca AB. The IBRELAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases
ibrelat

General Information

Serial Number77020749
Word MarkIBRELAT
Filing DateFriday, October 13, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 1, 2016
Registration Number3671363
Registration DateTuesday, August 25, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje S-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje S-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje S-15185
SE

Trademark Events

Event DateEvent Description
Friday, April 1, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, August 25, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2009NOTICE OF PUBLICATION
Thursday, April 30, 20091(B) BASIS DELETED; NEW BASIS REQUESTED
Friday, April 24, 2009NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 29, 2009PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, April 24, 2009FAX RECEIVED
Monday, April 27, 2009ASSIGNED TO PETITION STAFF
Friday, April 24, 2009PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Friday, April 24, 2009FAX RECEIVED
Wednesday, October 1, 2008ASSIGNED TO EXAMINER
Tuesday, September 23, 2008EXTENSION 3 GRANTED
Friday, September 19, 2008EXTENSION 3 FILED
Monday, September 22, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 19, 2008TEAS EXTENSION RECEIVED
Monday, May 5, 2008EXTENSION 2 GRANTED
Wednesday, April 23, 2008EXTENSION 2 FILED
Wednesday, April 23, 2008TEAS EXTENSION RECEIVED
Tuesday, November 20, 2007EXTENSION 1 GRANTED
Wednesday, October 24, 2007EXTENSION 1 FILED
Tuesday, November 13, 2007EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 13, 2007PETITION TO REVIVE-GRANTED
Tuesday, November 13, 2007TEAS PETITION TO REVIVE RECEIVED
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 24, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2007NOTICE OF PUBLICATION
Wednesday, December 6, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 5, 2006ASSIGNED TO LIE
Thursday, November 16, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 16, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, November 16, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, November 16, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 15, 2006ASSIGNED TO EXAMINER
Tuesday, October 17, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

ibrelat diseases infection gastrointestinal central system nervous inflammation respiratory preparations treatment